Journal Article Summary

The article investigates the effects of clopidogrel, a medication typically used to prevent blood clots, when combined with various anticancer drugs in mouse models of breast, colorectal, and prostate cancer. This research is important because while clopidogrel is known for its antiplatelet properties, there is conflicting evidence regarding its potential impact on cancer progression. Understanding how clopidogrel interacts with chemotherapy could help optimize treatment strategies for cancer patients, particularly those at risk for blood clots.

In the study, researchers used different mouse models to assess how clopidogrel affected tumor growth, metastasis, and the toxicity of several anticancer drugs, including 5-fluorouracil and cyclophosphamide. They found that clopidogrel enhanced the effectiveness of some chemotherapy agents, leading to reduced tumor growth and metastasis. However, it also decreased the effectiveness of other drugs like doxorubicin and cisplatin. Additionally, clopidogrel was shown to increase the toxicity of docetaxel while providing some protection against the toxicity of mitoxantrone.

The study has limitations, including its reliance on animal models, which may not fully replicate human responses to treatment. Patients should be cautious and discuss the use of clopidogrel with their healthcare providers, especially if they are undergoing chemotherapy. The findings suggest that while clopidogrel may have beneficial effects in certain combinations, it can also pose risks, highlighting the need for careful evaluation and personalized treatment plans in cancer therapy.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Denslow Agnieszka, Świtalska Marta, Jarosz Joanna, Papiernik Diana, Porshneva Kseniia, Nowak Marcin, Wietrzyk Joanna. Clopidogrel in a combined therapy with anticancer drugs—effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models. PLoS ONE 2017. DOI: 10.1371/journal.pone.0188740. PMID: 29206871. PMCID: PMC5716579.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]